BUFORD, Ga.--(BUSINESS WIRE)--Theragenics Corporation (NYSE:TGX), a medical device company serving the surgical products and prostate cancer treatment markets, will release its third quarter consolidated financial results before the market opens on Thursday, October 30. Following the release, the Company will host a conference call at 11:00 a.m. Eastern.
